溶血尿毒综合征
The hemolytic-uremic syndrome.
作者信息
Brasher C, Siegler R L
出版信息
West J Med. 1981 Mar;134(3):193-7.
Abstract
Our experience with 61 episodes of the hemolytic-uremic syndrome in 60 patients showed a mean patient age of 3 years and a higher incidence of the disease during the summer months. Diarrhea, often bloody, preceded the other features of the illness in 93 percent of the cases. Hemolytic anemia, hematuria and proteinuria occurred in all of the patients. Thrombocytopenia and severe azotemia (blood urea nitrogen greater than 100 mg per dl) occurred in 74 percent and 72 percent of the children, respectively. Blood transfusions were necessary in 64 percent and dialysis was required in 54 percent of the cases. Mortality was low (5 percent) and 85 percent of the children had a complete recovery.
摘要
我们对60例患者的61次溶血尿毒综合征发作的经验表明，患者平均年龄为3岁，且该疾病在夏季发病率较高。在93%的病例中，腹泻（通常为血性）先于疾病的其他特征出现。所有患者均出现溶血性贫血、血尿和蛋白尿。74%的儿童出现血小板减少症，72%的儿童出现严重氮质血症（血尿素氮大于100mg/dl）。64%的病例需要输血，54%的病例需要透析。死亡率较低（5%），85%的儿童完全康复。
相似文献
1
The hemolytic-uremic syndrome.溶血尿毒综合征
West J Med. 1981 Mar;134(3):193-7.
2
The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota.明尼苏达州溶血尿毒综合征的流行病学及临床特征
N Engl J Med. 1990 Oct 25;323(17):1161-7. doi: 10.1056/NEJM199010253231703.
3
[Hemolytic uremic syndrome. Evaluation of clinical and prognostic factors].[溶血性尿毒症综合征。临床及预后因素评估]
An Esp Pediatr. 1993 Nov;39(5):391-4.
4
[Hemolytic-uremic syndrome in Chile: clinical features, evolution and prognostic factors].[智利的溶血性尿毒症综合征：临床特征、病程及预后因素]
Rev Med Chil. 2008 Oct;136(10):1240-6. Epub 2009 Jan 15.
5
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.大肠杆菌O157:H7感染期间的相对肾脏保护作用：与静脉补液扩容的关系
Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236.
6
[Hemolytic uremic syndrome: a complication of acute gastroenteritis in children].[溶血尿毒综合征：儿童急性胃肠炎的一种并发症]
Dakar Med. 2001;46(1):25-8.
7
[Diagnosis and clinical features of hemolytic uremic syndrome].[溶血尿毒综合征的诊断与临床特征]
Nihon Rinsho. 1993 Jan;51(1):210-4.
8
Failure of fresh frozen plasma infusions to alter the course of hemolytic uremic syndrome.输注新鲜冰冻血浆未能改变溶血性尿毒症综合征的病程。
Child Nephrol Urol. 1988;9(1-2):38-41.
9
Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome.溶血尿毒综合征急性期红细胞输血需求与肾脏疾病严重程度之间的关系。
Pediatr Nephrol. 2015 Dec;30(12):2115-9. doi: 10.1007/s00467-015-3147-x. Epub 2015 Jul 4.
引用本文的文献
1
The Glomerular Endothelium Restricts Albumin Filtration.肾小球内皮限制白蛋白滤过。
Front Med (Lausanne). 2021 Nov 29;8:766689. doi: 10.3389/fmed.2021.766689. eCollection 2021.
2
Sub-Lethal Dose of Shiga Toxin 2 from Enterohemorrhagic Escherichia coli Affects Balance and Cerebellar Cytoarchitecture.肠出血性大肠杆菌产生的志贺毒素2亚致死剂量影响平衡和小脑细胞结构。
Front Microbiol. 2016 Feb 10;7:133. doi: 10.3389/fmicb.2016.00133. eCollection 2016.
3
Shiga toxin type-2 (Stx2) induces glutamate release via phosphoinositide 3-kinase (PI3K) pathway in murine neurons.2型志贺毒素（Stx2）通过磷酸肌醇3激酶（PI3K）途径诱导小鼠神经元释放谷氨酸。
Front Mol Neurosci. 2015 Jul 14;8:30. doi: 10.3389/fnmol.2015.00030. eCollection 2015.
4
Early erythropoietin in post-diarrheal hemolytic uremic syndrome: a case-control study.腹泻后溶血性尿毒症综合征早期促红细胞生成素：一项病例对照研究
Pediatr Nephrol. 2015 Feb;30(2):339-44. doi: 10.1007/s00467-014-2911-7. Epub 2014 Aug 21.
5
Guidelines for the management and investigation of hemolytic uremic syndrome.溶血性尿毒症综合征的管理与调查指南。
Clin Exp Nephrol. 2014 Aug;18(4):525-57. doi: 10.1007/s10157-014-0995-9.
6
Dexamethasone rescues neurovascular unit integrity from cell damage caused by systemic administration of shiga toxin 2 and lipopolysaccharide in mice motor cortex.地塞米松可挽救由全身性施用志贺毒素 2 和脂多糖引起的小胶质细胞损伤导致的小鼠运动皮层神经血管单元的完整性。
PLoS One. 2013 Jul 23;8(7):e70020. doi: 10.1371/journal.pone.0070020. Print 2013.
7
Hemolytic-uremic syndrome in asir region.阿西尔地区的溶血尿毒综合征
J Family Community Med. 1996 Jan;3(1):53-7.
8
Rasburicase for hyperuricemia in hemolytic uremic syndrome.拉布立酶治疗溶血尿毒综合征的高尿酸血症。
Pediatr Nephrol. 2012 Feb;27(2):325-9. doi: 10.1007/s00467-011-2047-y. Epub 2011 Nov 17.
9
Distribution of Gb(3) Immunoreactivity in the Mouse Central Nervous System.小鼠中枢神经系统中Gb(3)免疫反应性的分布
Toxins (Basel). 2010 Aug;2(8):1997-2006. doi: 10.3390/toxins2081997.
10
In vitro prostacyclin production in the hemolytic-uremic syndrome.溶血尿毒综合征中前列环素的体外生成
West J Med. 1986 Feb;144(2):165-8.
本文引用的文献
1
CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis.
Am J Dis Child. 1980 Sep;134(9):869-72. doi: 10.1001/archpedi.1980.02130210053014.
2
The importance of nonrenal involvement in hemolytic-uremic syndrome.非肾脏受累在溶血尿毒综合征中的重要性。
Pediatrics. 1980 Jan;65(1):115-20.
3
An analysis of the results of therapy in 67 cases of the hemolytic-uremic syndrome.67例溶血尿毒综合征治疗结果分析。
J Pediatr. 1971 Mar;78(3):420-5. doi: 10.1016/s0022-3476(71)80221-4.
4
Hemolytic-uremic syndrome.溶血尿毒综合征
J Pediatr. 1972 Jan;80(1):1-16. doi: 10.1016/s0022-3476(72)80445-1.
5
Heparin therapy in the hemolytic-uremic syndrome.溶血尿毒综合征中的肝素治疗。
J Pediatr. 1973 Aug;83(2):271-5. doi: 10.1016/s0022-3476(73)80490-1.
6
The hemolytic-uremic syndrome.溶血尿毒综合征
Nephron. 1973;11(2):174-92. doi: 10.1159/000180229.
7
Hyperuricemia in the hemolytic-uremic syndrome.溶血尿毒综合征中的高尿酸血症。
Am J Dis Child. 1976 Aug;130(8):854-6. doi: 10.1001/archpedi.1976.02120090064011.
8
Renal microangiopathy of the hemolytic-uremic syndrome in childhood.儿童溶血尿毒综合征的肾微血管病
Nephron. 1976;17(3):188-203. doi: 10.1159/000180723.
9
The hemolytic uremic syndrome.
Pediatr Clin North Am. 1976 Nov;23(4):761-77. doi: 10.1016/s0031-3955(16)33359-4.
10
The hemolytic-uremic syndrome: experience at a center in the Midwest.溶血尿毒综合征：美国中西部某中心的经验
Am J Dis Child. 1978 Jan;132(1):59-62. doi: 10.1001/archpedi.1978.02120260061015.
Zotero 插件